The COVAX program, created by the World Health Organization (OMS) and the Alliance for GAVI Vacancies to distribute antiquated vacancies worldwide, sent 26 million vacancies to Latin American countries, mainly from AstraZeneca, between March.
Agreed with the list of distribution published by GAVI, 18 Latin American countries are included among the 142 that received the first 237 million doses that COVAX would manage over the next three months.
Colombia, which is the first country in the world to have a lot of these vacancies, will receive more than a million doses of water in Mayo.
Without embargo, the countries of Latin America that have the most vacancies through this program will be Brazil (9.1 million) and Mexico (5.5 million).
Argentina will receive 1.9 million doses; Peru, 1.2 million; Chile, 818,000; Ecuador, 756,000; Bolivia, 672,000; Paraguay, 304,000; and Uruguay, 148,000.
Venezuela does not appear on the distribution list because “the dates are not very clear”, but there will be a dose, according to GAVI’s executive director, Seth Berkley.
In Central America there will be beneficiaries of the Costa Rica program, which will receive up to 218,000 doses, El Salvador (225,000), Guatemala (724,000), Honduras (424,000), Nicaragua (432,000) and Panama (184,000).
Between the Caribbean, Dominican Republic tends to 463,000 doses, while Cuba does not accept any decision to join COVAX, Berkley explained.
The most vacant countries in Maya (more than 10 million each) have their own nations with large populations, such as Bangladesh, Indonesia, Nigeria and Pakistan.
Ghana converts this past week in the first part of the world to receive vacancies through this solidarity platform, which has very different vacancies in Cambodia, Angola, Nigeria and the Democratic Republic of Congo.
The distribution program “will cover the course of the pandemic and the form in which it responds to sanitary emergencies”, OMS Director-General, Tedros Adhanom Ghebreyesus, about what is considered the mayor and more complex global munitions operation of history.
COVAX has this year the distribution in 2021 at least 2,000 million doses, 1,300 million of them in poor countries.
Berkley’s announcement in the press release that this figure is projected to increase to 2,500 million doses (1,800 million for developed countries).
Forman part of the platform 190 lands, of which a centenarian has collaborated on its financing, while the 90 most economically poor economies do not pay for the vacancies they assign.
In Latin America enters this group Bolivia, El Salvador, Honduras and Nicaragua.
In addition to the majority of vacancies it intends to send to AstraZeneca (the majority of companies manufactured by the Serum Institute of India), it is additionally distributed up to 1.2 million doses of the vaccine developed jointly by Pfizer / BioNTech, which also collaborates with COVAX.
A portion of these last vacancies is destined for Latin America in Colombia, which will receive 117,000 doses; El Salvador (51,000), Bolivia (92,000) and Peru (117,000).
Berkley states that soon to cooperate with COVAX the pharmaceutical pharmaceuticals Johnson & Johnson, which will donate 500 million doses, and Novavax, which has established a principle agreement for 1,100 million doses.
The initial list of beneficiaries published does not include important antique car manufacturers such as the United States, United Kingdom, China or Russia, nor any countries in the European Union that have contributed financially to COVAX.
The reason is that the Mayor of developed countries has opted to voluntarily withdraw the dose reception has contracted directly with the producers, which they are allowed to be among the first to receive the vacancies.
This mode allows COVAX vacancies to be sent primarily to countries that have received no dose escalation.
The rich COVAX donor countries that he received received vacancies in this first round in Canada, New Zealand and Monaco, as well as South Korea.